Literature DB >> 6201403

Somatomedin carrier proteins.

G L Smith.   

Abstract

The somatomedins, such as the insulin-like growth factors I and II, somatomedins A and C, and multiplication-stimulating activity, are small, growth hormone dependent polypeptides which are the assumed mediators of growth hormone action on extraskeletal tissues. The somatomedins are unique among polypeptide hormones in that they exist in serum as two high molecular weight complexes of approximately 150 000 and 60 000 molecular weight. Little, if any, free hormone is present in plasma or serum. These circulating complexes appear to represent the reservoir for these hormones since none is stored in any other tissue and the circulating concentration (approx. 1 microgram/ml) exceeds the biologically active concentration of the free hormone by many fold. Many recent investigations regarding the subunit composition of the two serum carrier protein complexes and their effect on the biological activity of the somatomedins have revealed an elaborate system of intense physiological control ultimately aimed at delivering somatomedin to its specific receptor on the surface of the target cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201403     DOI: 10.1016/0303-7207(84)90058-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  A new serum-free method of measuring growth factor activities for human breast cancer cells in culture.

Authors:  M Ogasawara; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1988-09

2.  Human recombinant insulin-like growth factor I. I. Development of a serum-free medium for clonal density assay of growth factors using BALB/c 3T3 mouse embryo fibroblasts.

Authors:  T L Riss; K P Karey; B D Burleigh; D Parker; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

3.  Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy.

Authors:  P Arner; S Sjöberg; M Gjötterberg; A Skottner
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

4.  Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.

Authors:  H J Cornell; G Enberg; A C Herington
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

5.  Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage.

Authors:  D J McQuillan; C J Handley; M A Campbell; S Bolis; V E Milway; A C Herington
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

6.  Two insulin-like growth factor I messenger RNAs are expressed in human liver.

Authors:  P Rotwein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

7.  Identification and characterization of specific binding proteins for growth hormone in normal human sera.

Authors:  A C Herington; S Ymer; J Stevenson
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours.

Authors:  J G Reeve; J A Payne; N M Bleehen
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

Review 9.  Role and Importance of IGF-1 in Traumatic Brain Injuries.

Authors:  Annunziato Mangiola; Vera Vigo; Carmelo Anile; Pasquale De Bonis; Giammaria Marziali; Giorgio Lofrese
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.